Prelude Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$561K Buy
1,186
+214
+22% +$108K 0.04% 465
2025
Q4
$454K Sell
972
-3,683
-79% -$1.71M 0.03% 581
2025
Q3
$1.98M Sell
4,655
-945
-17% -$366K 0.15% 165
2025
Q2
$2.15M Buy
5,600
+32
+0.6% +$11.5K 0.21% 125
2025
Q1
$1.92M Buy
5,568
+536
+11% +$172K 0.15% 155
2024
Q4
$1.51M Buy
5,032
+2,059
+69% +$720K 0.09% 255
2024
Q3
$1.21M Sell
2,973
-2,870
-49% -$1.05M 0.07% 335
2024
Q2
$1.88M Sell
5,843
-10,031
-63% -$3.26M 0.13% 203
2024
Q1
$5.29M Sell
15,874
-16,620
-51% -$5.08M 0.28% 56
2023
Q4
$8.8M Buy
32,494
+5,122
+19% +$1.27M 0.58% 21
2023
Q3
$6.73M Buy
27,372
+20,086
+276% +$5.5M 0.44% 28
2023
Q2
$2.21M Sell
7,286
-9,513
-57% -$2.64M 0.14% 180
2023
Q1
$4.43M Sell
16,799
-5,207
-24% -$1.32M 0.27% 72
2022
Q4
$5.28M Sell
22,006
-4,795
-18% -$1.07M 0.27% 70
2022
Q3
$4.93M Buy
26,801
+3,016
+13% +$601K 0.18% 87
2022
Q2
$4M Buy
23,785
+4,013
+20% +$862K 0.11% 140
2022
Q1
$4.96M Buy
19,772
+18,531
+1,493% +$4.65M 0.14% 128
2021
Q4
$319K Sell
1,241
-2,062
-62% -$505K 0.01% 1281
2021
Q3
$802K Buy
+3,303
New +$808K 0.02% 659
2021
Q2
Sell
-17,456
Closed -$3.29M 1769
2021
Q1
$3.29M Buy
17,456
+10,708
+159% +$1.89M 0.08% 178
2020
Q4
$1.11M Buy
6,748
+2,769
+70% +$405K 0.03% 452
2020
Q3
$496K Sell
3,979
-436
-10% -$54K 0.02% 445
2020
Q2
$429K Buy
+4,415
New +$459K 0.02% 508
2020
Q1
Sell
-517
Closed -$76K 1662
2019
Q4
$76K Sell
517
-1,858
-78% -$250K ﹤0.01% 1200
2019
Q3
$286K Buy
2,375
+1,136
+92% +$147K 0.01% 675
2019
Q2
$167K Sell
1,239
-268
-18% -$33.9K 0.01% 793
2019
Q1
$196K Sell
1,507
-824
-35% -$111K 0.01% 717
2018
Q4
$290K Sell
2,331
-2,612
-53% -$351K 0.02% 618
2018
Q3
$688K Sell
4,943
-3,062
-38% -$381K 0.04% 450
2018
Q2
$821K Buy
8,005
+3,869
+94% +$391K 0.05% 386
2018
Q1
$401K Buy
+4,136
New +$401K 0.03% 498
2016
Q4
Sell
-1,837
Closed -$139K 1647
2016
Q3
$139K Buy
1,837
+1,197
+187% +$91.7K 0.01% 702
2016
Q2
$49K Buy
+640
New +$50.5K 0.01% 1014
2015
Q3
Sell
-993
Closed -$90K 1603
2015
Q2
$90K Buy
+993
New +$79.6K 0.01% 918
2015
Q1
Sell
-250
Closed -$18K 2023
2014
Q4
$18K Sell
250
-940
-79% -$66.1K ﹤0.01% 1755
2014
Q3
$84K Buy
+1,190
New +$78.6K 0.01% 1162
2014
Q1
Sell
-13,450
Closed -$642K 1970
2013
Q4
$642K Sell
13,450
-6,300
-32% -$291K 0.11% 269
2013
Q3
$844K Buy
19,750
+18,750
+1,875% +$733K 0.14% 178
2013
Q2
$36K Buy
+1,000
New +$38.7K 0.01% 859

Other funds holding HCA

Prelude Capital Management's HCA Position: Q1 2026 in Review

Prelude Capital Management increased its HCA Healthcare (HCA) stake by 22% in Q1 2026, buying an estimated $108K and bringing the position to 1,186 shares worth $561K. The position accounts for 0.04% of the portfolio, ranked #465.

Prelude Capital Management first reported a position in HCA in Q2 2013 and has held it in 39 quarters since. The position peaked at $8.8M in Q4 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Prelude Capital Management held 1,186 shares of HCA Healthcare worth $561K as of Q1 2026.
  • Prelude Capital Management bought 214 HCA Healthcare shares in Q1 2026, an estimated $108K.
  • HCA Healthcare made up 0.04% of Prelude Capital Management's portfolio in Q1 2026, its #465 holding.
  • Prelude Capital Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 39 quarters since.
  • Prelude Capital Management's HCA Healthcare position peaked at $8.8M in Q4 2023.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.